26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease.

Published

Journal Article (Review)

Full Text

Duke Authors

Cited Authors

  • Cheitlin, MD; Douglas, PS; Parmley, WW

Published Date

  • October 1994

Published In

Volume / Issue

  • 26 / 10 Suppl

Start / End Page

  • S254 - S260

PubMed ID

  • 7934748

Pubmed Central ID

  • 7934748

Electronic International Standard Serial Number (EISSN)

  • 1530-0315

International Standard Serial Number (ISSN)

  • 0195-9131

Language

  • eng